Product Program year 2025 Source: CMS Open Payments

Advate

Biological Hematology

NDC 0944-3045-10

Open in the dashboard

General payments

$1,089,785

1,927 payments

Research payments

$1,718,903

14 payments

Through program year 2025, $1,089,785 in general payments and $1,718,903 in research payments were reported against Advate (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $11,220 108
2024 General $84,401 232
2023 General $66,991 192
2023 Research $9,100 6
2022 General $23,577 47
2021 General $150,618 145
2020 General $200,439 277
2020 Research $75,417 2
2019 General $552,540 926
2019 Research $1,634,386 6

Breakdown

Who paid General payments · program years 2019–2025
  1. Shire North American Group Inc $552,540 926 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $537,245 1,001 payments
Top recipients General payments · program year 2025
  1. Jonathan Roberts Pediatrics · Peoria, IL $3,212 29% · 2 payments
  2. Nathan Connell Hematology · Boston, MA $1,606 14% · 1 payment
  3. Angela Weyand Pediatric Hematology-Oncology · Ann Arbor, MI $1,606 14% · 1 payment
  4. Craig Seaman Hematology · Pittsburgh, PA $1,405 13% · 1 payment
  5. Kim Schafer Nurse Practitioner, Family · Sacramento, CA $723 6% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatrics $3,289 29% · 4 practitioners
  2. Hematology Internal Medicine $3,011 27% · 2 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $1,950 17% · 12 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $1,086 10% · 16 practitioners
  5. Hematology & Oncology Internal Medicine $654 6% · 25 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $3,212 29% · 1 recipient
  2. Michigan $1,662 15% · 4 recipients
  3. Massachusetts $1,606 14% · 1 recipient
  4. California $1,583 14% · 31 recipients
  5. Pennsylvania $1,405 13% · 1 recipient

The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to ADVATE
Billing code Providers Services Paid by Medicare
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified J7192 4 13,603,433 $15,340,368

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

1,927 general · 14 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record